Calypso Medical Technologies, Inc.
CalypsoR Medical Technologies, Inc. is a medical device company developing innovative tools and therapies for the radiation oncology market. Their Calypso 4DR Localization System and BeaconR Transponder enable radiation therapists to localize a target organ and track organ motion continuously and in real-time during radiation therapy.
| Company | Calypso Medical Technologies, Inc. |
|---|---|
| URL | http://calypsomedical.com/ |
The acquisition provides that Varian will pay approximately $10 million for Calypso plus potential earnouts based on unit sales of Calypso products achieved beyond thresholds over the next 30 months.
Calypso Medical Sponsors the Great Prostate Cancer Challenge Race Series in Five Cities
Calypso Medical Technologies, Inc. announced a partnership with ZERO – The Project to End Prostate Cancer to sponsor the Great Prostate Cancer Challenge Race Series (GPCC) in five cities nationwide.
First Multi-Site Study Evaluates New Targeted Radiation Approach for Shortened, Safer Prostate Cancer Treatment
The first multi-institutional study evaluating a new form of radiation treatment for prostate cancer coupled with sophisticated real-time tumor tracking is now underway at the University of Michigan Health System.
Calypso Medical Technologies, Inc. announced the results of two clinical studies demonstrating that real-time tumor tracking with the Calypso® System during five-day stereotactic body radiotherapy (SBRT) for prostate cancer enabled clinicians to reduce treatment margins and minimize dosimetric impact of prostate motion.
Calypso Medical Names Edward Vertatschitsch President and Chief Executive Officer 01.26.2011
Calypso Medical Technologies, Inc. announced that it has named Edward Vertatschitsch, Ph.D., president and chief executive officer.
Calypso Medical Technologies, Inc. announced that the Siteman Cancer Center at the Washington University School of Medicine is the first facility in the world to equip their Calypso® System with Dynamic Edge™ Gating technology.
Calypso Medical Receives FDA 510(k) Clearance for Dynamic Edge Gating Technology 10.07.2010
Calypso Medical Technologies, Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Calypso® System with Dynamic Edge™ Gating Technology.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today
First Installment of Calypso System in the United Kingdom at the Royal Marsden Hospital 03.17.2010
Calypso System Tumor Tracking Technology Enables Precision-Guided Delivery During Radiation for Prostate Cancer at Leading Cancer Center
Emory's Winship Cancer Institute announced today that it is the first cancer facility in Georgia to provide prostate cancer patients with "GPS for the body" in order to provide more precise radiation therap...
Calypso(R) Medical Reports Leading Cancer Centers Standardize Their Prostate Cancer Therapy on GPS for the Body(R)
Los Angeles, CA - October 28, 2007 - Calypso Medical is announcing results of scientific investigations with the CalypsoR 4D Localization System? to be presented at the American Society for Therapeutic Radiology and Oncology (ASTRO) 49th An...
Seattle, WA and Sunnyvale, CA, - October 28, 2007 - Calypso Medical and IMPAC Medical Systems, an Elekta company, have identified product collaboration projects which will further enable integration of oncology management systems with the Calypso
CalypsoR Medical Technologies, Inc., Investigators Present Progress at AAPM 49th Annual Meeting
Patients will benefit from early adoption of technology from Seattle-based Calypso Medical
Calypso(R) Medical Technologies, Inc., $42.2M Private Equity Financing Provides Expansion Capital
Seattle, WA - January 5, 2007 - Today, CalypsoR Medical Technologies, Inc., announced closure of its Series D private equity financing, totaling $42.2 million. Apothecary Capital, LLC (Chicago, IL), Glenview Capital Management (New York, ...
Philadelphia, PA - November 5, 2006 - CalypsoR Medical announces its intention to collaborate on future product offerings with IMPAC Medical Systems, Inc. (IMPAC), an Elekta company.
Philadelphia, PA - November 5, 2006 - CalypsoR Medical announces product development advancement on strategic collaboration efforts with Philips at the 48th Annual American Society for Therapeutic Radiology and Oncology (ASTRO) meeting, N...
CalypsoR Medical Technologies, Inc. Investigators Present Real-Time Prostate Motion Data at ASTRO's 48th Annual Meeting
Calypso(R) Medical Receives FDA 510(k) Clearance for the Calypso(R) 4D Localization System
First continuous, real-time method to locate and ontinuously track tumor motion during cancer treatment
CalypsoR Medical Technologies, Inc. Investigators Present Progress at ASTRO's 47th Annual Meeting
CalypsoR Medical Technologies, Inc., Investigators Present Progress at AAPM 47th Annual Meeting
Seattle, WA - July 19, 2005 - CalypsoR Medical Technologies, Inc. today announced that it has begun clinical studies for patients with prostate cancer receiving external beam radiation therapy. The study will evaluate the usability and sa...
11/01/2010MVC Corporation Changes Name to Mitsui & Co. Global Investment, Ltd.
11/01/2010MCVP Changes Name and Relocates Office
09/27/2010Notice on Relocation of MVC Head Office
09/24/2010Mitsui Ventures invested USD 5 M in S*BIO
06/17/2008 | Taro InabaBoehringer Ingelheim announced an agreement to acquire Actimis Pharmaceuticals, Inc. one of our portfolio firms.